Champions Oncology, Inc. (CSBR) stock
CSBRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 11, 2026Score 10/30238% above fair value
$4.44−0.15 (-3.30%)
Close on Nov 18, 2026Market cap $61.80MP/E –Yield –
Champions Oncology price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Champions Oncology's price to book ratio was 17.1× on Nov 11, 2026, against 25.7× a year earlier. Over the last 5 years it ranged from 6.1× to 221.1×, with a median of 18.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 17.1× | −5.9 |
| 2025 | Dec 31, 2025 | 23.0× | −149.4 |
| 2024 | Dec 31, 2024 | 172.4× | +135.9 |
| 2023 | Nov 30, 2023 | 36.5× | +29.8 |
| 2022 | Dec 30, 2022 | 6.7× | −7.3 |
| 2021 | Dec 31, 2021 | 14.0× | −6.9 |
| 2020 | Dec 31, 2020 | 20.9× | −24.9 |
| 2019 | Dec 31, 2019 | 45.8× | +0.8 |
| 2018 | Dec 31, 2018 | 45.0× | −69.3 |
| 2017 | Dec 29, 2017 | 114.3× | +105.6 |
| 2016 | Dec 30, 2016 | 8.7× | +1.1 |
| 2015 | Dec 31, 2015 | 7.6× | −89.9 |
| 2014 | Nov 28, 2014 | 97.5× | – |
See a number that looks wrong?